Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Prof Lars Fugger
Prof Lars Fugger

Congratulations for their recent success go to:

Prof Lars Fugger - Wellcome Trust Senior Investigator Award

Prof Fugger received the award for his work on Multiple Sclerosis. His group is seeking to understand the molecular basis for interactions between genetic and environmental risk factors through a multidisciplinary approach, which combines analysis of both clinical samples and humanised transgenic in vivo models. Their goal is to develop new therapeutic avenues for MS by gaining insight into disease pathways, which can be manipulated through both novel drugs and drug repositioning. 

Prof Fugger trained at the University of Copenhagen and at Stanford University. He became Professor of Clinical Immunology at the University of Oxford in 2004 and Professor of Neuroimmunology in 2007 in the NDCN.

Prof Kia Nobre – MRC Partnership Grant

Prof Kia Nobre and colleagues at the Oxford Centre for Human Brain Activity were part of a collaboration of MEG researchers across the UK to receive a £1.3m Partnership Grant from the MRC to enhance MEG training, collaboration, and data sharing.

Dr Martin Turner – MRC Senior Clinician Scientist Fellowship

Dr Turner is a Consultant Neurologist and Clinician Scientist in NDCN. His research focus is the neurodegenerative disorder Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS) in its commonest form.

Dr Gwenaelle Douaud – MRC Career Development Award

Dr Douaud is part of the FMRIB Analysis Group. She focuses on translational research from imaging methods to applied human neuroscience, such as brain maturation and ageing, and with a particular emphasis on neurodegenerative disorders (Alzheimer's disease, movement disorders and motor neuron disease).

Dr Chris Butler - MRC Scientist-Clinician Fellowship

Dr Butler is investigating the functional and neural basis of accelerated forgetting in patients with transient epileptic amnesia.

 

Similar stories

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.

Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize

In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.

New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases

Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.